Home > Drug Search >
  • company_query: Biogen
  •   > 
Drug Filter
Category:
chemistry (24) biology (28)
Status:
Approved (14) NDA Filing (3) BLA Filing (1) Phase Ⅲ (5) Phase Ⅱ (16) Phase Ⅰ (13)
Clinical Stage:
Pending (3) Active (29) Discontinued (6)
Bio-Type:
Vaccine (1) Recombinant cytokines (3) Whole antibody (16) Fab fragment (1) ADC (1) Fusion protein (2)
Indication:
Acute rejection in renal transplantation (1) Alzheimer's disease (AD) (2) Anemia (1) Atherosclerosis (1) CD20-positive follicular lymphoma (1) Chronic lymphocytic leukemia (CLL) (1) Crohn's disease (2) Dyslipidemia (2) Gastrointestinal stromal tumors (GISTs) (1) HBV infection (2) HCV infection (2) Heart failure (2) Hepatocellular carcinoma (HCC) (1) HIV infection (3) Hyponatremia (1) Idiopathic pulmonary fibrosis (IPF) (1) Idiopathic thrombocytopenic purpura (ITP) (1) Multiple sclerosis (MS) (9) Neuropathic pain (1) Non small cell lung cancer (NSCLC) (1) Non-alcoholic fatty liver disease (NAFLD) (1) Non-Hodgkin B-cell lymphomas (2) Non-Hodgkin’s lymphoma (NHL) (2) Parkinson's disease (PD) (1) Postherpetic neuralgia (PHN) (1) Kidney disorders (1) Psoriasis (3) Rejection of organ transplantation (1) Rheumatoid arthritis (RA) (4) Sjoegren's syndrome (2) Solid tumours (6) Systemic lupus erythematosus (3) Type 2 diabetes (3) Colorectal cancer (1) Microscopic polyangiitis (1) Granulomatosis with polyangiitis (1) Trigeminal neuralgia (1) Hemophilia A (1) Hemophilia B (1) Hematological cancer (1) Spinal muscular atrophy (1) Autoimmune diseases (2) Smallpox infection (1) Lupus nephritis (1) Cutaneous lupus erythematosus (1) Diabetic neuropathy (1) Liver cancer (1) Inflammation (1) Muscular atrophy (1) Optic neuritis (1)
Country:
Aprv. Year:
1996 (1) 1997 (2) 2002 (1) 2004 (1) 2013 (1) 2014 (2) 2016 (1) 2017 (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 3 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top